TNF-α and leptin activate the α-isoform of class II phosphoinositide 3-kinase

被引:25
|
作者
Ktori, C [1 ]
Shepherd, PR [1 ]
O'Rourke, L [1 ]
机构
[1] UCL, Dept Biochem & Mol Biol, London WC1E 6BT, England
关键词
D O I
10.1016/S0006-291X(03)00933-1
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The class II PI 3-kinases are known to be activated by growth factors and chemokines but to date there are no reports of cytokine mediated regulation. Further, the intracellular signalling mechanisms regulating the class-II PI 3-kinases are poorly understood. We investigated the effects of the cytokines TNFalpha and leptin on the activity of the alpha isoform of the class II PI 3-kinase (PI3K-C2alpha) and find that these stimulate the enzyme 2-fold and 3-fold, in CHO cells and J774.2 macrophages, respectively. The stimulation by leptin was not accompanied by recruitment of any tyrosine phosphorylated proteins to PI3K-C2alpha and no shift in electrophoretic mobility was noted. Furthermore, we demonstrate that the actions of both cytokines are blocked by the MEK inhibitor PD98059. These findings indicate that the cytokines activate PI3K-C2alpha and do so by a mechanism that requires activation of the ERK pathway and thus differs from the mechanism used by insulin to activate the enzyme. (C) 2003 Elsevier Science (USA). All rights reserved.
引用
收藏
页码:139 / 143
页数:5
相关论文
共 50 条
  • [21] Class II phosphoinositide 3-kinase defines a novel signaling pathway in cell migration
    Maffucci, T
    Cooke, FT
    Foster, FM
    Traer, CJ
    Fry, MJ
    Falasca, M
    JOURNAL OF CELL BIOLOGY, 2005, 169 (05): : 789 - 799
  • [22] Phosphoinositide 3-kinase class II beta is a novel target in breast cancer therapy
    Abbott, J.
    Pineiro, R.
    Oliviero, M. A.
    Lattanzio, R.
    Piantelli, M.
    Bilancio, A.
    Maffucci, T.
    Falasca, M.
    BREAST CANCER RESEARCH, 2010, 12 : S5 - S5
  • [23] Phosphoinositide 3-kinase class II beta is a novel target in breast cancer therapy
    J Abbott
    R Pineiro
    MA Oliviero
    R Lattanzio
    M Piantelli
    A Bilancio
    T Maffucci
    M Falasca
    Breast Cancer Research, 12
  • [24] Phosphoinositide 3-Kinase Signaling Can Modulate MHC Class I and II Expression
    Chandrasekaran, Sanjay
    Sasaki, Maiko
    Scharer, Christopher D.
    Kissick, Haydn T.
    Patterson, Dillon G.
    Magliocca, Kelly R.
    Seykora, John T.
    Sapkota, Bishu
    Gutman, David A.
    Cooper, Lee A.
    Lesinski, Gregory B.
    Waller, Edmund K.
    Thomas, Susan N.
    Kotenko, Sergei V.
    Boss, Jeremy M.
    Moreno, Carlos S.
    Swerlick, Robert A.
    Pollack, Brian P.
    MOLECULAR CANCER RESEARCH, 2019, 17 (12) : 2395 - 2409
  • [25] The class II phosphoinositide 3-kinase C2β is not essential for epidermal differentiation
    Harada, K
    Truong, AB
    Cai, T
    Khavari, PA
    MOLECULAR AND CELLULAR BIOLOGY, 2005, 25 (24) : 11122 - 11130
  • [26] Targeting class IA phosphoinositide 3-kinase isoforms in glioblastoma
    Hoeland, K.
    Boller, D.
    Frei, K.
    Arcaro, A.
    EJC SUPPLEMENTS, 2010, 8 (05): : 91 - 92
  • [27] Isoform-specific phosphoinositide 3-kinase inhibitors from an arylmorpholine scaffold
    Knight, ZA
    Chiang, GG
    Alaimo, PJ
    Kenski, DM
    Ho, CB
    Coan, K
    Abraham, RT
    Shokat, KM
    BIOORGANIC & MEDICINAL CHEMISTRY, 2004, 12 (17) : 4749 - 4759
  • [28] Isoform Selective Phosphoinositide 3-Kinase gamma and delta Inhibitors and Their Therapeutic Potential
    Ghigo, Alessandra
    Hirsch, Emilio
    RECENT PATENTS ON INFLAMMATION & ALLERGY DRUG DISCOVERY, 2008, 2 (01) : 1 - 10
  • [29] Phosphoinositide 3-kinase signaling
    Cantley, LC
    Fruman, D
    Yballe, C
    Rameh, L
    FASEB JOURNAL, 2000, 14 (08): : A1411 - +
  • [30] A class II phosphoinositide 3-kinase plays an indispensable role in hepatitis C virus replication
    Maehama, Tomohiko
    Fukasawa, Masayoshi
    Date, Tomoko
    Wakita, Takaji
    Hanada, Kentaro
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2013, 440 (01) : 150 - 156